Suppr超能文献

神经嵴衍生的间充质祖细胞增强颅同种异体移植物的整合。

Neural crest-derived mesenchymal progenitor cells enhance cranial allograft integration.

机构信息

Orthopaedic Stem Cell Research Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.

出版信息

Stem Cells Transl Med. 2021 May;10(5):797-809. doi: 10.1002/sctm.20-0364. Epub 2021 Jan 29.

Abstract

Replacement of lost cranial bone (partly mesodermal and partly neural crest-derived) is challenging and includes the use of nonviable allografts. To revitalize allografts, bone marrow-derived mesenchymal stromal cells (mesoderm-derived BM-MSCs) have been used with limited success. We hypothesize that coating of allografts with induced neural crest cell-mesenchymal progenitor cells (iNCC-MPCs) improves implant-to-bone integration in mouse cranial defects. Human induced pluripotent stem cells were reprogramed from dermal fibroblasts, differentiated to iNCCs and then to iNCC-MPCs. BM-MSCs were used as reference. Cells were labeled with luciferase (Luc2) and characterized for MSC consensus markers expression, differentiation, and risk of cellular transformation. A calvarial defect was created in non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice and allografts were implanted, with or without cell coating. Bioluminescence imaging (BLI), microcomputed tomography (μCT), histology, immunofluorescence, and biomechanical tests were performed. Characterization of iNCC-MPC-Luc2 vs BM-MSC-Luc2 showed no difference in MSC markers expression and differentiation in vitro. In vivo, BLI indicated survival of both cell types for at least 8 weeks. At week 8, μCT analysis showed enhanced structural parameters in the iNCC-MPC-Luc2 group and increased bone volume in the BM-MSC-Luc2 group compared to controls. Histology demonstrated improved integration of iNCC-MPC-Luc2 allografts compared to BM-MSC-Luc2 group and controls. Human osteocalcin and collagen type 1 were detected at the allograft-host interphase in cell-seeded groups. The iNCC-MPC-Luc2 group also demonstrated improved biomechanical properties compared to BM-MSC-Luc2 implants and cell-free controls. Our results show an improved integration of iNCC-MPC-Luc2-coated allografts compared to BM-MSC-Luc2 and controls, suggesting the use of iNCC-MPCs as potential cell source for cranial bone repair.

摘要

替代丢失的颅骨(部分中胚层和部分神经嵴衍生)具有挑战性,包括使用无活力的同种异体移植物。为了使同种异体移植物恢复活力,已经使用骨髓间充质基质细胞(中胚层来源的 BM-MSCs)取得了有限的成功。我们假设用诱导的神经嵴细胞-间充质祖细胞(iNCC-MPCs)涂覆同种异体移植物可改善小鼠颅缺损中的植入物与骨的整合。从真皮成纤维细胞重编程人类诱导多能干细胞,分化为 iNCCs,然后分化为 iNCC-MPCs。BM-MSCs 用作参考。用荧光素酶(Luc2)标记细胞,并对 MSC 共识标记物的表达、分化和细胞转化风险进行特征描述。在非肥胖型糖尿病/严重联合免疫缺陷(NOD/SCID)小鼠中创建颅骨缺损,并植入同种异体移植物,有无细胞涂层。进行生物发光成像(BLI)、微计算机断层扫描(μCT)、组织学、免疫荧光和生物力学测试。iNCC-MPC-Luc2 与 BM-MSC-Luc2 的特征比较表明,两种细胞类型在体外的 MSC 标记物表达和分化没有差异。在体内,BLI 表明两种细胞类型至少存活 8 周。在第 8 周时,μCT 分析显示 iNCC-MPC-Luc2 组的结构参数增强,BM-MSC-Luc2 组的骨体积增加,与对照组相比。组织学表明,与 BM-MSC-Luc2 组和对照组相比,iNCC-MPC-Luc2 同种异体移植物的整合得到改善。在细胞接种组中,在同种异体移植物-宿主界面检测到人类骨钙素和胶原 I 型。与 BM-MSC-Luc2 植入物和无细胞对照相比,iNCC-MPC-Luc2 组还表现出更好的生物力学性能。我们的结果表明,与 BM-MSC-Luc2 和对照组相比,iNCC-MPC-Luc2 涂层同种异体移植物的整合得到改善,表明 iNCC-MPC 可作为颅骨修复的潜在细胞来源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6855/8046069/502b46ed99a6/SCT3-10-797-g003.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验